Midwest Research Group and St. Charles Psychiatric Associates present a unique combination of professional services.
St. Charles Psychiatric Associates is a group of physicians, a nurse practitioner, and several psychotherapists working together in an outpatient clinic to provide a variety of medication and therapeutic services.
Midwest Research Group, a subsidiary of St. Charles Psychiatric Associates, helps develop new tools for the treatment of a wide variety of mental health conditions. Midwest Research Group operates out of a state-of-the-art facility and conducts clinical trials that provide valuable information to evaluate how new medications may help people. Some studies see how medications used for one symptom may also help other symptoms. Examples include: medication used to stabilize moods may also help memory in Alzheimer’s patients or a medication that is used to treat ADHD may benefit Autism symptoms; or a once daily pill may be more effective if given through a monthly injection. The research studies conducted at Midwest Research Group are typically part of worldwide studies to help determine the best treatment options for people with a variety of mental health conditions including depression, anxiety, ADHD, binge-eating disorder, autism, bipolar disorder, schizophrenia and various types of dementia including Alzheimer’s disease.
Greg Mattingly, MD was recently interviewed by Reuters and Med City News, among others, about the current and future state of ADHD research. Read what he had to say:
To be considered for a research study, please complete the following information: